UBS maintains Meritage Homes at Buy, lowers price target to $85 from $88

What happened

UBS kept its Buy rating on Meritage Homes but lowered its price target to $85 from $88, a 3.4% decrease. UBS said the revised target implied 31.8% upside from the October 30 closing price of $64.47.

Confirmed

Global impact / market context

The lower target signals UBS sees less potential price appreciation than before, while its Buy rating remains unchanged. For investors, the revised target may shape expectations for Meritage Homes shares, but it is an analyst estimate, not a promised return or company forecast.

Analyst inference

The article lists four other recent analyst targets, ranging from $59 to $82, with ratings spanning Sell, Hold, In-Line and Buy. UBS’s $85 target is above that range, though the notes may differ in timing and assumptions.

Confirmed

What to watch

1. Compare future analyst updates with UBS’s $85 target and the other reported estimates; changes in ratings or targets could shift investor expectations for Meritage Homes shares. Analyst inference
2. Watch for company updates on home sales, revenue and costs, which could provide evidence that supports or challenges analysts’ expectations for the business. Analyst inference
3. The article gives no explanation for UBS’s target reduction or new business assumptions, so any stated rationale in a later update would clarify the change. Confirmed

Evidence

• Original source link unavailable